ISLB 2023


Yüksel Ürün

Yüksel Ürün: Turkey
Categories: Invited Speakers
Dr. Ürün is a professor of medicine at the Ankara University School of Medicine in Turkey, specializing in Medical Oncology. Since joining Ankara University School of Medicine in 2009, he has played a pivotal role in advancing medical knowledge and expertise in his field. To further enrich his understanding of oncology, Dr. Ürün pursued a fellowship at the renowned Dana Farber Cancer Institute, affiliated with Harvard Medical School in Boston, USA. During this time, he gained invaluable experience and exposure to cutting-edge research and treatments, augmenting his expertise in cancer care.
Upon returning to Turkey, Dr. Ürün’s passion for enhancing cancer treatment and research led him to establish the Turkish Oncology Group Kidney Cancer Consortium (TKCC). Actively engaged in the global oncology community, Dr. Ürün is a prominent member of prestigious international and national oncology organizations. Notably, he is a member of the EORTC GU group and the Advanced Prostate Cancer Consensus Conference (APCCC). Additionally, he serves as a faculty member in the ESMO Genitourinary Tumors, Prostate group. Dr. Ürün has been selected as a participant in the prestigious American Society of Clinical Oncology’s (ASCO) Leadership Development Program class of 2023-2024.
Dr. Ürün’s primary research interests encompass various aspects of genitourinary cancers, including epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. As a principal investigator in numerous clinical trials, he has made remarkable contributions to the scientific community, authoring over 100 peer-reviewed articles, presentations, and book chapters.
Beyond his academic pursuits, Dr. Ürün is deeply committed to promoting diversity and equity in education and healthcare. He is passionate about fostering representation and engagement of underrepresented groups in clinical trials, recognizing the importance of inclusivity and accessibility in the pursuit of medical advancements. Through his passion for patient care and research, he continues to inspire and drive positive change within the field of medicine.